Introduction

Fermented foods have been a substantial part of the human diet for several years1. Additionally, fermented food constituted of plants, meat, or milk can be maintained for a longer time than fresh raw food2. Fermented foods comprise a good reservoir of probiotic bacteria. Probiotics are strains of microorganisms that exert positive health effects when administered to humans and animals. Probiotics are mainly lactic acid bacteria (LAB) belonging to the genera Lactobacillus and Bifidobacterium3. Other genera can also be used as probiotics, such as Bacillus, Enterococcus, Pediococcus, and several yeasts4. LAB are mostly gram-positive, anaerobic rods that are derived from the human gastrointestinal tract5.

LAB were originally isolated from fermented food in single or mixed cultures but are the best candidate for enhancing the fermentation process6. They also have the capacity to survive during the fermentation process7. LAB isolated from fermented food with the capacity to improve digestive health are considered probiotics8. They are typically used as potential microbe-containing food supplements and are regarded as a crucial functional food constituent9. In addition to fermented food, LAB can exist in a variety of habitats, such as gastrointestinal tracts (GIT), oral cavities, human and animal vaginal tracts, silages, and composts10. LAB confer a variety of advantageous health benefits to the host, including improving the digestion process11, controlling inflammatory bowel diseases12, maintaining the healthy balance of the gut microbiota13, and modulating immune function14. Lacticaseibacillus rhamnosus, a LAB strain previously isolated from human breast milk has been reported to modulate the intestinal microbiota and immune system15. Additionally, Lactobacillus plantarum supplementation has been shown to stimulate lead detoxification by increasing the rate of lead excretion in the animal feces15. Furthermore, some LAB strains possess anticancer and antidiabetic effects16,17. The exopolysaccharides of Lactobacillus strains have been proved to have anticancer, antidiabetic, antioxidant, antimicrobial and immunostimulatory effects18,19,20,21,22. Therefore, LAB have been considered to be the best candidate probiotics.

One of the most important features of LAB is the production of significant metabolites such as lactic acid, organic acids, antioxidants, and antimicrobial compounds23. These metabolites play an important role in maintaining and modulating the gut microbiota. LAB supplementation in animals enhances growth rate performance, leading to higher meat production and lower rates of disease incidence24. Consequently, probiotics have been widely used as feed additives and as proper alternatives to antibiotics. For example, probiotic supplementation in poultry can improve the immune response and growth rate25. Other animals, such as pigs26, silver foxes27, ostriches28, and raccoon dogs27, have also shown similar outcomes. Currently, investigating new probiotics, particularly from newly discovered species, has become an important practice29.

LAB should be assessed and evaluated as potential probiotic candidates and must fulfill all the necessary quality assurance criteria for probiotic selection30. These criteria include antibiotic resistance, showing no virulence or toxigenic activity, tolerance to GIT conditions, adherence capacity to intestinal epithelial cells, and autoaggregation and coaggregation activities31. In addition, probiotics must maintain their stability and vitality inside the host and during the food processing and preservation process. Therefore, the main purpose of the current study is to isolate and assess LAB from different fermented food products in vitro and in vivo to explore new safe probiotics with promising antimicrobial, antioxidant, and anticancer applications.

Materials and methods

Sample collection, LAB isolation and culture conditions

Eight fermented food products were collected from markets in Egypt to isolate potential probiotic LAB. These eight products included plant-based luncheon meat, soy sausage, corned beef, soybean, pickles, kareish cheese, rayeb milk, and full-fat milk. All these samples were screened for the presence of probiotic LAB. The dilution-plate method was applied to isolate LAB on de Man, Rogosa, and Sharpe (MRS) agar at 37 °C for 24–48 h. The colonies grown on MRS media were collected and subjected to biochemical and morphological analysis. Gram-positive, catalase-negative, and lactose-fermenting bacteria were only selected and regarded as LAB candidates. All LAB isolates were maintained in 20% glycerol at − 20 °C for further analysis (Fig. 1).

Figure 1
figure 1

Experimental workflow for the isolation and assessment of LAB as probiotics from different fermented food sources.

Bacterial strains

The indicator pathogenic bacteria used in this study were purchased from American-type culture collection (ATCC). These pathogens include Escherichia coli O157:H7 ATCC 700,728, Pseudomonas aeruginosa ATCC 35,032, Salmonella enterica subsp. enterica serovar Typhimurium ATCC 14,028, Staphylococcus aureus ATCC 25,923, Methicillin-resistant Staphylococcus aureus (MRSA) ATCC 43,300, Bacillus cereus ATCC 33,018, and Listeria monocytogenes ATCC 19,115. All pathogenic strains were cultured and propagated on a tryptone soya yeast extract broth (TSYEB) medium for coaggregation and antagonistic activity assays.

Safety assessment of the LAB strains

Hemolysis assay

The hemolytic activity of the selected LAB strains was determined according to Maragkoudakis et al.32. LAB strains were grown overnight in MRS broth. Following incubation, an aliquot of each overnight culture was streaked onto a blood agar base (Oxoid, UK) containing sheep blood 5% (v/v). The plates were incubated at 37 °C for 24 h. The grown LAB strains were screened for α-, β-, or γ-hemolysis. LAB strains that showed no blood or γ-hemolysis were considered safe.

Antibiotic susceptibility assay

The LAB isolates were tested for their antibiotic susceptibility against commonly used antibiotics using a Kirby-Bauer disc diffusion assay35. The antibiotics applied in this study were ceftriaxone (30 µg), penicillin G (2 units), ampicillin (10 µg), gentamicin (10 µg), oxacillin (1 µg), streptomycin (10 µg), tetracycline (30 µg), vancomycin (30 µg), ciprofloxacin (5 µg), chloramphenicol (30 µg), erythromycin (10 µg), and kanamycin (30 µg). MRS plates inoculated with LAB isolates and with antibiotic discs placed on the surface of agar were incubated at 37 °C for 24 h. The diameters of the inhibition zones were measured, and the results were interpreted according to the guidelines of the Clinical and Laboratory Standards (CLSI 2014).

Probiotic evaluation of the LAB strains

Bile salt tolerance

The ability of LAB strains to survive in the presence of 0.3% bile salt was assessed. Overnight LAB cultures (1% v/v) were inoculated into MRS broth supplemented with 0.3% bile salt, followed by subsequent incubation. The viability of LAB strains was recorded at 0 and 6 h of incubation by determining the colony-forming unit (CFU) counts of strains on MRS agar.

NaCl and phenol tolerance

The tolerance of LAB strains to NaCl was determined by inoculating the overnight cultures of LAB strains (1% v/v) into MRS broth containing 8% NaCl. Following incubation at 37 °C for 6 h, the optical density of the grown LAB cultures at a wavelength of 600 nm (OD600nm) was measured using a spectrophotometer (Metash UV-800, Shanghai, China) to assess their viability.

Similarly, the ability of LAB strains to tolerate high concentrations of phenol was assessed. Overnight cultures of LAB strains (1% v/v) were inoculated into MRS broth containing increasing concentrations of phenol (0.1–0.4%)33. The inoculated MRS broth tubes were incubated at 37 °C for 24 h. The viability of the strains was determined by measuring the OD600nm of grown LAB strains using a spectrophotometer.

Simulated gastric and intestinal juice survivability

The capacity of LAB strains to survive in the simulated human digestive system was investigated according to the method described by Botta et al.34. Briefly, overnight LAB cultures were centrifuged and resuspended in simulated gastric juice containing pepsin (pH 2)35. The inoculated flasks were subsequently incubated at 37 °C for 4 h in an orbital shaker at a speed of 200 rpm. The CFU counts of each selected LAB strain were determined at 0 and 4 h incubation by plating into MRS agar. The cells grown in simulated gastric juice were collected by centrifugation and washed in phosphate-buffered saline (PBS). The cells were then resuspended in simulated intestinal juice containing pancreatin (pH 6.8)36. Immediately after incubation at 37 °C for 4 h, the viability of LAB strains was recorded by determining the CFU counts as described earlier.

Autoaggregation and coaggregation assays

The autoaggregation capability of LAB strains was determined using the method described by Polak-Berecka et al.37 with some modifications. In short, the overnight LAB cultures were centrifuged and washed with PBS. The harvested cells were resuspended in 2 mL of PBS, and the OD600nm was adjusted to 0.25 ± 0.02. The bacterial suspension was incubated at 37 °C for 2 h. The absorbance of the bacterial suspension was measured at 600 nm using a spectrophotometer at 0 and 2 h time points. The autoaggregation activity was determined according to the following formula:

(1 − A0h/A2h) *100.

Where A2h denotes the absorbance at t = 2 h and A0h denotes absorbance at t = 0 h.

For the determination of the coaggregation capability of LAB strains, the bacterial suspensions were similarly prepared as described above. Two milliliters of each LAB strain and pathogen were mixed and incubated at 37 °C for 2 h. Control tubes contained 4 mL of each LAB strain and each pathogen. The absorbance of the mixed bacterial suspensions was measured at 600 nm after 2 h of incubation and compared to that of the control suspensions for probiotic and pathogen strains. The coaggregation activity was calculated as follows38: [1 − Amix/ (ALAB + Apathogen)/2]*100.

Where Amix denotes the absorbance of mixed suspensions, ALAB denotes the absorbance of control tubes containing LAB strains, and Apathogen denotes the absorbance of control tubes containing pathogens.

Cell hydrophobicity assay

The LAB cell hydrophobicity was assayed by measuring the percentage of bacterial adhesion to hydrocarbons39. Bacterial cells and xylene mixtures were prepared by mixing 2 mL of each LAB strain suspended in PBS at 108 CFU/mL with 2 mL of xylene. The mixture was then vortexed, and the OD600 of the aqueous phase was measured with a spectrophotometer. The affinity of LAB strains to xylene was calculated using the following equation: [(A0 − A30min)/A0] *100.

Antagonistic activity of LAB strains

The antimicrobial activity of LAB strains was determined using an agar-plug diffusion assay40. The LAB strains were streaked onto MRS agar and incubated at 37 °C for 5 days to allow the isolates to secrete their metabolites. After incubation, an agar plug was cut aseptically and placed on the surface of Mueller Hinton agar (Biolife, Italia) inoculated with the pathogen. The plates were incubated at 37 °C for 24 h. The antimicrobial activity was determined in terms of the inhibition zone diameters (mm) surrounding the agar plugs of each LAB strain.

Molecular identification of LAB strains

LAB strains were identified using 16S rRNA amplification and sequencing with universal forward (5′-AGAGTTTGATCMTGGCTCAG-3′) and reverse (5′-AAGGAGGTGATCCAGCC-3′) primers. Then, the PCR reactions were conducted using a previously described protocol41. The amplified PCR products were visualized using a gel electrophoresis and gel documentation system (Bio-Rad, USA) and then purified and sequenced. The 16S rRNA sequences were aligned with the bacterial sequences in the NCBI database using the basic local alignment search tool (BLAST). Phylogenetic analysis of the identified LAB strains was performed using the neighbor-joining method. The tree was constructed using the maximum composite likelihood method.

Cytotoxicity assessment of LAB strains against colon cancer cell line

The LAB strains were allowed to grow for five days in MRS broth. Cell-free supernatants were obtained by centrifugation of LAB cultures at 6000 rpm for 10 min (Hettich, Germany). The cell proliferation activity of LAB strains was measured against the human epithelial colorectal adenocarcinoma (Caco-2) cell line using the MTT (3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) cell viability assay. The Caco-2 cell line was provided from ATCC, USA, and routinely cultured in RPMI-1640 medium (Roswell Park Memorial Institute). This medium was supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin G sodium, 100 units/ml streptomycin sulfate, and 250 ng/ml amphotericin B (Nuaillé, France). Cells were kept at subconfluency at 37 °C in humidified air containing 5% CO2. For subculturing, monolayer cells were harvested after trypsin/EDTA treatment at 37 °C. Cells were used when confluence reached 75%. All cell culture materials were obtained from Cambrex Bioscience (Copenhagen, Denmark). The supernatants of LAB strains were initially diluted in the medium to obtain the desired concentrations for the assay. Cells (5 × 104 cells/well) in RPMI-1640 medium were plated in a flat-bottom 96-well microplate and treated with 20 µL of different concentrations of the LAB supernatants for 48 h at 37 °C in a humidified 5% CO2 atmosphere, except for the 20% v/v concentration, which was treated with 40 µL of the tested sample over 160 µL of the cells. The tested concentrations were 10, 5, 2.5, 1.25, and 0.625% (v/v). After incubation, the medium was removed, and an aliquot of 40 µL MTT solution/well was added and incubated for an additional 4 h. MTT crystals were solubilized by adding 180 µl of acidified isopropanol/well, and the plate was shaken at room temperature, followed by photometric determination of the absorbance at 570 nm using a microplate ELISA reader (FLUOstar OPTIMA, BMG LABTECH GmbH, Ortenberg, Germany)42. Four repeats were performed for each concentration, and the average was calculated. Data were expressed as the percentage of relative viability compared with the untreated cells, with cytotoxicity indicated by < 100% relative viability. The percentage of relative viability was calculated using the following equation:

(Absorbance of treated cells/Absorbance of control cells) × 100.

Rat model for LAB safety evaluation

At the Animal Health Research Institute in Egypt's Laboratory Animal House, 20 healthy mature Sprague Dawley albino male rats weighting 120 ± 5 g and aged 8 weeks were purchased and accommodated for one week before conducting the experiment. The animals were kept in metal cages under hygienic conditions of 14 h/10 h light/dark cycles, a temperature of 24 ± 4 °C, and a relative humidity of 60 ± 10%. The rats were divided randomly into five equal groups: the first group served as the control and was fed with 1 mL of PBS, the second, third, and fourth groups were fed with 109 CFU/mL of the Enterococcus faecium IS03 strain, Enterococcus lactis IS05 strain, Enterococcus massiliensis IS06 strain, and Lactiplantibacillus plantarum IS07 strain, respectively. Each group contained four rats. The sample size was calculated by power analysis using the G*power program43. All the researchers were aware of the group allocation at the different stages of the experiment. The trial has been running for three weeks, and all treatments have been received day after day. Ad libitum food and drink were provided before and during the experiment period. Loss of weight exceeding 20% of normal body weight was the humane endpoint for this study. There was no exclusion of any experimental group, any animals, any experimental units, or data points in this study. At the end of the experiment, all groups were sacrificed by decapitation under general anesthesia using a combination of ketamine (45 mg/kg) and xylazine (10 mg/kg) anesthetic agents. All experimental protocols were approved by the research ethics committee (REC) for experimental and animal studies at Cairo University, Egypt (approval number: CU II F 8 23). REC for experimental and animal studies regulated the handling and housing of the rats in compliance with institutional policies for laboratory animal use and care.

Biochemical determination

Immediately after drawing fresh blood samples, the sera were collected by centrifuging at 3000 rpm for 15 min. The alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), uric acid, and creatinine concentrations were determined using the clear supernatant serum that had been aspirated into dry sterile vials and stored at -20 °C. ALT and AST levels were measured using a calorimetric method as previously reported44,45. Alkaline phosphatase (ALP) was determined using a previously described method46. Uric acid and creatinine were measured using a calorimetry method47,48.

Liver, kidney, and spleen samples were sliced and stored at -80 °C for further analysis of catalase activity (CAT), reduced glutathione (GSH), and superoxide dismutase (SOD). Superoxide dismutase (SOD) and reduced glutathione (GSH) were detected in the liver, kidney, and spleen as described previously49,50.

Statistical analysis

Graphs and statistical analysis were conducted using R (version 3.2.5) and Adobe illustrator CC 2015. Student’s t test and the Mann‒Whitney–Wilcoxon test (nonparametric) were used to test the significance of comparisons. The variations were considered significant when the p value was ≤ 0.05.

Results

Isolation of LAB and in vitro safety evaluation

To obtain multiple LAB isolates to test their probiotic potentials, we isolated 100 bacterial isolates from eight fermented food sources on MRS agar media (Fig. 1). Only 19 isolates (5 isolates from soybean, 5 isolates from soy sausage, 3 isolates from plant-based luncheon meat, 3 isolates from pickles, and 3 isolates from corned beef) exhibited LAB properties, as they are Gram-positive, catalase-negative, and lactose-fermenters. To assess the in vitro safety of the isolated LAB, the isolates were submitted to the blood hemolysis test, where only 8 isolates (IS02, IS03, IS04, IS05, IS06, IS07, IS10, and IS18) showed no blood or γ-hemolysis (Fig. 1 and Table S1).

Bile salt tolerance of the LAB isolates

One of the most important criteria for probiotic bacteria is their tolerance to bile salt to ameliorate their survivability in the GIT. Therefore, we tested the ability of the eight selected LAB isolates to tolerate 0.3% bile salt in MRS media for 6 h. All 8 isolates showed good bile salt tolerance, as their CFU counts were not affected by the presence of bile salt in the media for 6 h (Fig. 2). However, only three isolates (IS02, IS03, and IS05) showed a significant increase in their CFU counts (P < 0.01, 0.0001, and 0.001, respectively) after 6 h of growth in the presence of bile salt (Fig. 2).

Figure 2
figure 2

Bile salt tolerance of the selected LAB isolates for 6 h. Data are represented as the means of three replicate values ± standard error of the mean. **P < 0.01; ***P < 0.001; ****P < 0.0001.

NaCl and phenol tolerance of the LAB isolates

All 8 isolates were tested for their tolerance to high concentrations of NaCl and phenol. Only six isolates (IS03, IS04, IS05, IS06, and IS07, and IS18) were shown to have good tolerance to high NaCl levels (8%) after incubation for 6 h. There was a significant increase in the OD of only two isolates (IS06 and IS07) after 6 h of growth in the presence of 8% NaCl (P < 0.01). Conversely, the other isolates showed reduced growth at high NaCl concentrations (Fig. 3a and Table S2). Furthermore, the six selected isolates showed variable growth responses toward increasing concentrations of phenol (0.1–0.4%). Only four isolates (IS03, IS05, IS06, and IS07) showed good tolerance to high concentrations of phenol after growth for 24 h (Fig. 3b).

Figure 3
figure 3

Tolerance of the selected LAB isolates to high concentrations of NaCl and phenol. (a) Tolerance to 8% (w/v) NaCl. (b) Tolerance to increasing concentrations of phenol (0.1–0.4%). The intensity of color in the heatmap reflects the OD of the bacterial growth at different concentrations. Data are represented as the means of three replicate values.

Survival in simulated gastric and intestinal juice (simulated human digestive system)

The ability of LAB to survive both gastric and intestinal juices promotes their potential as probiotics. Therefore, we examined the survivability of the four selected LAB isolates in the presence of simulated gastric juice (pH 2) and simulated intestinal juice (pH 6.8) successively for 4 h. The four isolates survived both simulated gastric and intestinal juices for 4 h (Fig. 4). There was no significant difference in the CFU counts for all four isolates at 4 h compared to their CFU counts at zero time.

Figure 4
figure 4

Survival of LAB isolates in simulated gastric (GA) and intestinal juices (IT) at 0 and 4 h of exposure. Data are represented as the means of three replicate values ± standard error of the mean.

Autoaggregation and coaggregation properties

All four isolates showed high autoaggregation percentages ranging from 78.37 ± 2.03 to 94.63 ± 4.07% after 2 h of growth (Table 1). Both IS05 and IS07 isolates exhibited significantly higher autoaggregation activities compared to IS03 and IS06 isolates. Consistently, all the isolates also showed high coaggregation capabilities with all tested pathogenic bacteria after 2 h of growth (Table 1). However, the coaggregation capacity differed among the selected LAB isolates, indicating that the coaggregation capacity is strain-specific and contingent upon the pathogenic bacteria being tested. IS06 exhibited the highest coaggregation capacity with E. coli O157:H (P < 0.05), Staph. aureus, and B. cereus (P < 0.01). While IS07 showed the highest coaggregation capacity with L. monocytogenes (P < 0.01), Ps. aeruginosa, and Salm. enterica serovar Typhimurium (P < 0.05).

Table 1 The aggregation capacities of the selected LAB isolates.

Cell surface hydrophobicity

To assess the cell surface hydrophobicity of the isolates, the bacterial affinity for xylene was measured. All four isolates exhibited a high adhesion percentage to xylene. IS07 showed the highest adhesion percentage (90.49 ± 2.67). While IS03, IS05, and IS07 showed 88.70 ± 3.05, 86.40 ± 2.43, and 87.72 ± 2.98 adhesion percentages, respectively.

Antimicrobial activity of LAB isolates against pathogenic bacteria

The antagonistic effect of the four selected LAB isolates was examined against seven indicator pathogenic bacterial strains using an agar plug diffusion assay. All isolates were shown to exert antagonistic activities toward all pathogens tested in this study. The diameter of the inhibition zone against each pathogen varied from one LAB isolate to another, ranging from 8 ± 0.00 to 29 ± 0.46 mm (Table 2). IS03 displayed the highest inhibitory effect against Salm. enterica serovar Typhimurium (20 ± 0.43 mm) and Ps. aeruginosa (25 ± 0.23 mm). IS05, IS06, and IS07 displayed the highest inhibitory effect against L. monocytogenes.

Table 2 Distribution of the Inhibition zone diameters (mm) of LAB isolates against indicator pathogenic bacteria.

Antibiotic susceptibility

The antibiotic resistance pattern of the selected LAB isolates to 12 commonly used antibiotics was examined using a disc diffusion assay (Table 3). In view of the results, all LAB isolates exhibited multiple antibiotic resistance to more than three antibiotics. All LAB isolates exhibited antibiotic resistance to oxacillin, ciprofloxacin, and vancomycin. In contrast, they were all susceptible to penicillin (except the IS06 isolate) and chloramphenicol. Both IS03 and IS05 isolates were resistant to nine antibiotics.

Table 3 The antibiotic resistance profile of LAB isolates toward 12 commonly used antibiotics using disk diffusion assay.

Cytotoxicity against human colon cancer cell line

The cell proliferation activity of the four selected isolates was measured against the Caco-2 cell line using the MTT Cell Viability Assay. All isolates showed different cytotoxic effects. The cell proliferation activities of the LAB isolates and the IC50 are illustrated in Figs. 5 and 6, respectively. IS03 showed the least cytotoxic effect, with an IC50 value equal to 23.6% v/v. IS06 and IS07 showed moderate cytotoxicity, with IC50 values equal to 11.2 and 13.7% v/v, respectively. While IS05 showed the most cytotoxic effect, with the lowest IC50 value equal to 9.2% v/v.

Figure 5
figure 5

The cell proliferation activity of selected LAB strains on the Caco-2 cell line. The values represent the means ± standard error of four independent experiments.

Figure 6
figure 6

The IC50 of the tested LAB strains on the Caco-2 cell line. Data are mean values ± standard error of four independent experiments.

Molecular identification of the LAB isolates

The four selected LAB isolates shown to have potential probiotic properties were identified using 16S rRNA sequencing. The obtained 16S rRNA sequences were analyzed using the NCBI blast tool and deposited in NCBI GenBank (https://www.ncbi.nlm.nih.gov/genbank/). The accession numbers of IS03, IS05, IS06, and IS07 strains in NCBI GenBank are OQ709412, OQ709413, OQ709414, and OQ709415, respectively. The LAB strains were identified as Enterococcus faecium (IS03), Enterococcus lactis (IS05), Enterococcus massiliensis (IS06), and Lactiplantibacillus plantarum (IS07). Furthermore, Fig. 7 shows the phylogenetic tree of the sequenced LAB strains based on their 16S rRNA sequences in relation to the closest bacterial strains.

Figure 7
figure 7

Phylogenetic tree of the potential LAB strains isolated and sequenced in this study (marked with **) based on their 16S rRNA sequences in relation to the closest strains.

In vivo safety evaluation of LAB strains

The safety of potential LAB probiotic strains was assessed in rats by feeding five rat groups with PBS as a control and the four LAB isolates. The body weight gain (BWG) was determined after 21 days of feeding with LAB strains. There was no significant difference observed in the BWG of rats treated with Enterococcus faecium, Enterococcus lactis, and Enterococcus massiliensis. However, there was a significant increase in the percentage of BWG in the rats treated with Lactiplantibacillus plantarum compared to the control group (P < 0.05) (Fig. 8a). Additionally, the organ index was determined for the kidney, liver, and spleen in all rat groups. Compared to the control group, there was no significant difference in the organ index in all rats treated with LAB strains (Fig. 8b). Furthermore, we determined liver and kidney functions by measuring the levels of indicator enzymes such as ALT, AST, and ALP. Uric acid and creatinine concentrations in the blood of all experimental rat groups were also determined as indicators of kidney function. According to the results, the levels were normal in all groups, and no significant changes in liver and kidney functions were observed in all LAB-treated rat groups compared to the control group (data not shown).

Figure 8
figure 8

Impact of feeding rats with potential LAB probiotic strains on the body weight gain percentage and organ index of experimental rats. (a) Body weight gain. Data are represented as the median of four replicate values. *P < 0.05 in Mann‒Whitney-Wilcoxon test. (b) Organ index analysis of the kidney, liver, and spleen in all treated rat groups. Data are represented as the means of four replicate values ± standard error of the mean.

Effect of LAB supplementation on antioxidant levels in rats

In this study, the levels of two key antioxidant compounds, SOD and GSH, was determined in the kidney, liver, and spleen. All experimental rat groups treated with LAB strains exhibited a significant increase in the levels of SOD enzyme in the kidney, liver, and spleen compared to the control group (Fig. 9a). On the other hand, only LAB-treated rats with Enterococcus faecium (IS03) and Lactiplantibacillus plantarum (IS07) exhibited a significant increase in GSH levels in the kidney and liver compared to the control group (Fig. 9b). The rat group treated with Enterococcus massiliensis (IS06) exhibited significantly increased GSH levels only in the kidney.

Figure 9
figure 9

Antioxidant levels in the kidney, liver and spleen in all experimental rat groups. (a) SOD enzyme levels. (b) GSH levels. Data are represented as the means of four replicate values ± standard error of the mean. *P < 0.05, **P < 0.01; ***P < 0.001; ****P < 0.0001.

Antioxidant status in the cellular extracts of LAB strains

To confirm the increased antioxidant activity of LAB strains shown in vivo, we measured the activity of both SOD and GSH-Px enzymes in the cellular extracts of LAB strains. The results showed that all the potential LAB probiotic strains exhibited high SOD enzyme activity. Only LAB strains IS05 and IS07 showed high GSH-Px enzyme activity (Fig. S1).

Discussion

Fermented foods comprise a good reservoir of probiotic bacteria. Potential LAB probiotic strains, such as Enterococcus faecium, Streptococci spp., and Lactobacillus plantarum, have been extensively isolated from fermented food sources, including pickles, milk products, and fermented sausage51,52. The administration of LAB to humans and animals as an effective alternative to antibiotics and to confer multiple health benefits has recently attracted tremendous attention. Previous studies have shown that the application of probiotics to feed supplements is a promising strategy for providing a significant impact on livestock53. However, it is necessary to systemically characterize and identify these bacteria to ensure their safety and effectiveness. Consequently, the purpose of this study was to analyze and assess the probiotic properties, health benefits, and safety of LAB isolated from different fermented food sources in vitro and in vivo. In our research, we isolated and identified four LAB strains as potential probiotics from fermented food sources. They were identified as Enterococcus faecium, Enterococcus lactis, Enterococcus massiliensis, and Lactiplantibacillus plantarum. Enterococcus faecium and Enterococcus lactis strains were previously isolated from soy milk54 and found in high numbers in fermented cheese and sausage55. Ent. faecium strains were reported in previous studies to have probiotic properties and to confer positive health effects56. Ent. lactis strains were also reported to be safe and to have probiotic properties57,58. Lactiplantibacillus plantarum strains have been isolated previously from different food products and were shown to have probiotic properties59,60. Furthermore, Ent. massiliensis was reported exclusively in this study as a potential probiotic strain with different applications.

The capacity of LAB strains to tolerate bile salt in the duodenum and extreme pH conditions in the stomach is one of the key factors affecting their survival rate in the host. According to our results, LAB strains exhibited varying levels of bile salt resistance, which may be attributed to the expression of proteins related to bile salt resistance61. In this study, the viability of both Ent. faecium IS03 and Ent. lactis IS05 strains was significantly increased after exposure to bile salts for six hours. Enterococcus bacteria are the indigenous microflora inhabiting the GI tract of humans62 and possess different benefits in the dairy industry. Therefore, Enterococcus strains are expected to survive extreme GI conditions. Furthermore, our LAB strains showed good survivability in simulated gastric juice at pH 2 and simulated intestinal juice at pH 6.8. These findings are probably due to the presence of strain- or species-specific tolerance mechanisms63 with potential resistance-producing bacterial proteins64.

In this study, only six LAB isolates showed high tolerance to 8% NaCl, and only two isolates showed a significantly high tolerance. These two isolates were isolated from soy sausage and pickles. This is in agreement with previous studies showing that LAB isolated from dairy products, pickles, chickens, and meats can tolerate high NaCl concentrations65,66,67. These results represent desirable characteristics for potential LAB probiotics that could promote bacterial growth and the production of advantageous metabolites. In addition, the ability of LAB strains to survive high levels of NaCl is relevant to industrial and food preservation applications. Moreover, only four LAB strains demonstrated good survival at increasing concentrations of phenol. Phenol is a toxic metabolite secreted by microbes in the GIT when some amino acids are deaminated68. Consequently, potential probiotic strains should have the capacity to tolerate phenolic conditions to survive under GIT conditions. LAB strains were reported previously to exhibit varying degrees of phenol tolerance69.

Surface colonization of LAB strains in the GIT due to autoaggregation, coaggregation, and hydrophobicity is one of the key factors affecting probiotic evaluation. The autoaggregation feature enables microorganisms of the same species to adhere to the intestinal mucosa70. In contrast, coaggregation allows intracellular adhesion between various strains of microorganisms, which is dependent on the capacity of strains to interact with pathogens. Therefore, aggregation could play a vital role in the host’s defense mechanisms against infections71. In this study, the four LAB strains were observed to have efficient autoaggregation and coaggregation capabilities after only 2 h of growth. This could be due to the intricate interactions among bacterial cell-surface proteins or other secreted metabolites. The aggregation phenotype is mainly dependent on the surrounding environment and potential internal factors71. Therefore, it is necessary to identify the factors involved in the aggregation phenotype of these strains. Additionally, LAB exhibiting aggregation-promoting factors may promote the elimination of pathogens by maintaining the balance of gut microbial interactions and the coaggregation mechanism. Cell-surface hydrophobicity is another major factor for evaluating the probiotic properties of LAB strains. The ability of probiotic strains to adhere to enterocyte cells is directly measured by their hydrophobicity72, which is a favorable property of probiotics. All four LAB strains examined in this work showed high cell-surface hydrophobicity, with values higher than 85%. This suggests that the adherence capability of these LAB strains to the intestinal layer would be very efficient. In accordance with a previous report73, a hydrophobicity of 40% or above is used as a standard for selecting potential LAB probiotics. Thus, the high autoaggregation, coaggregation, and hydrophobicity potentials of the LAB strains isolated in this study can aid their presence and persistence in the human and animal intestinal tract to improve intestinal health.

A substantial amount of evidence suggests that several probiotic bacteria can exhibit antagonistic activity against intestinal pathogenic microbes74,75,76. As more considerable attention has been given to the dissemination of antibiotic resistance, antimicrobial activity against pathogenic microbes has garnered extensive concern77. Putative probiotics should harbor antimicrobial properties against both Gram-positive and Gram-negative bacteria. All four LAB strains showed high antimicrobial activities against the pathogenic bacteria tested in this study. In fact, the antimicrobial activity is relevant to coaggregation activity78. Probiotic bacteria produce antimicrobial substances during their intimate contact with pathogenic bacteria to eliminate pathogens79.

Potential probiotics are characterized by harboring intrinsic and non-transmissible genetic factors that aid them in developing antibiotic resistance to different antibiotics without serving as a reservoir of antibiotic resistance genes80. It is believed that antibiotic resistance in probiotics is essential for the survival of antibiotics in the GI tract81. The intestinal flora can be restored after antibiotic treatment due to the presence of probiotics with intrinsic resistance82. The antibiotic resistance of LAB strains against different types of antibiotics is a major criterion for their safety assessment as probiotics83. All four LAB strains in this study showed antibiotic resistance to oxacillin, ciprofloxacin, and vancomycin. On the other hand, they showed susceptibility to penicillin and chloramphenicol. This is in accordance with previous studies showing that most of the LAB strains isolated from the intestine of pigs and poultry were resistant to oxacillin, ciprofloxacin, and vancomycin and susceptible to penicillin and chloramphenicol65,78. Vancomycin-resistant LAB strains were also isolated from fermented cream82.

One of the most promising studied areas of the probiotics’ health-promoting effects is their anticancer activity84,85. Colorectal cancer (CRC) has recently emerged as one of the major diseases linked to gastrointestinal issues. According to epidemiologic studies, this cancer type constitutes up to 9% of all fatal cancers86. Intriguingly, certain probiotic bacteria can reduce the risk of CRC incidence87. There are different anti-CRC mechanisms employed/deployed by probiotics, including anti-inflammatory responses, DNA damage reduction, altering the enzyme activity of intestinal microflora, competitive colonization, and apoptosis induction88,89. In this study, all four LAB strains inhibited the proliferation of the colon cancer cell line (Caco-2) in a dose-dependent manner. The Ent. lactis IS05 strain showed the highest anti-colon cancer activity, while Ent. massiliensis and Lactiplantibacillus plantarum showed moderate anti-colon cancer activity. Lactobacillus strains were previously shown to inhibit the proliferation of cancerous cells, especially the Caco-2 cell line, by initiating the apoptotic process90. Additionally, both Ent. faecium and Ent. lactis were shown to have an antiproliferative effect against the Caco-2 cell line91,92. Ent. massiliensis was reported here for the first time to have cytotoxic effects against the cancer cell line Caco-2.

Although LAB as probiotics have long been considered safe for use, the pathogenicity and virulence of LAB strains must be assessed. None of the four selected LAB strains showed hemolysis of the sheep blood erythrocytes, indicating their non-virulent nature. Thus, these strains can be regarded as promising candidates for safe probiotics. Additionally, the safety profile of the four LAB strains was assessed by testing their effects on the overall health status of rats. No abnormal behavior, body weight loss, or changes in organ indices were detected after 21 days of feeding rats with the LAB strains. Also, the levels of indicator enzymes for liver and kidney functions were normal in rats supplemented with the LAB strains. This indicates that these four strains have no adverse effects on the general health of rats. Moreover, the growth performance of rats supplemented with the Lactiplantibacillus plantarum strain significantly increased. These findings support the evidence that LAB supplementation may benefit the health and well-being of animals.

Reactive oxygen species (ROS) can be produced in the human body due to different physiological processes93. The accumulation of ROS such as superoxide, hydrogen peroxide, and hydroxyl free radicals leads to severe damage to macromolecules such as DNA, lipids, and proteins. This would result in organ dysfunction94. To detoxify and scavenge free radicals, LAB can produce antioxidant enzymes. In addition, LAB produce exopolysaccharides22,95, lipoteichoic acid, and cell-surface proteins96 that may be responsible for their antioxidant activity. The levels of ROS can be reduced by the activity of antioxidant enzymes such as SOD, CAT, and the glutathione/glutathione reductase system. In our study, all four LAB strains demonstrated significantly high levels of SOD antioxidant enzyme in the liver, kidney, and spleen of the rats. However, all LAB strains except Ent. lactis IS05 showed high GSH levels in only the kidney and liver tissues of the rats. This is in line with previous studies showing that Lactiplantibacillus plantarum dramatically increased the levels of both SOD and GSH-Px enzymes in the liver of mice97. Additionally, Lactiplantibacillus plantarum isolated from raw fermented meat products showed high antioxidant activity98. Enterococcus species isolated from dairy and meat products were shown to exhibit high antioxidant activity99. These results indicate that LAB supplementation in humans and animals would enhance antioxidant activities, and LAB could be used in food processing as natural antioxidants instead of chemical antioxidants.

Conclusion

This study showed that exploring new probiotics in fermented food products is a paramount avenue to attain a good supply of probiotic LAB strains with different health benefits. LAB isolated from different fermented food products are considered safe and harbor probiotic properties. Four LAB strains were shown in this study to tolerate bile salt and endure extreme conditions in the GIT. They were also shown to have autoaggregation, coaggregation, and hydrophobicity properties. In addition, these LAB strains were shown to have anti-pathogen, anti-colon cancer, and antioxidant activities. Enterococcus massiliensis is a novel probiotic strain isolated from soy sausage with different benefits. These findings indicate that fermented food products are a good source of probiotic bacteria.